-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the official website of the State Food and Drug Administration showed that the febuxostat tablets of Shandong Langnuo Pharmaceutical and the febuxostat tablets of Chongqing Shenghuaxi Pharmaceutical Co.
, Ltd.
were approved for production in four categories on the same day, and they were deemed to have been reviewed
.
According to data from Meinenet, febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in Chinese cities.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%
.
, Ltd.
were approved for production in four categories on the same day, and they were deemed to have been reviewed
.
According to data from Meinenet, febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in Chinese cities.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%
.
November 19, 2021, the release of the drug approval document pending information release
Febuxostat is a xanthine oxidase inhibitor that reduces serum uric acid concentration by inhibiting uric acid synthesis, and is suitable for long-term treatment of hyperuricemia in patients with gout
.
.
TOP5 terminal anti-gout products in physical pharmacies in Chinese cities
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
Febuxostat tablets were developed by Japan's Teijin Pharmaceuticals and were approved for listing in the United States in 2009, and are now on the market in many countries and regions including China
.
According to data from Minai.
com, Febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in cities in China
.
.
According to data from Minai.
com, Febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in cities in China
.
2021E China's urban physical pharmacy terminal febuxostat brand pattern
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In 2020, the sales of febuxostat tablets in physical pharmacies in Chinese cities exceeded the 500 million mark, and it is expected to decline in 2021
.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%; Jiangsu Hengrui Pharmaceutical and Hangzhou Zhuyangxin Pharmaceutical rank second and third
.
.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%; Jiangsu Hengrui Pharmaceutical and Hangzhou Zhuyangxin Pharmaceutical rank second and third
.
Up to now, there are 10 manufacturers of febuxostat tablets, of which 9 companies including Jiangsu Wanbang Biochemical and Pharmaceutical Group and Jiangsu Hengrui Medicine have been evaluated
.
In addition, nine companies including Chengdu Better Pharmaceuticals, Qingdao Baiyang Pharmaceuticals, and Zhejiang Asia-Pacific Pharmaceuticals submitted listing applications and are under review and approval
.
.
In addition, nine companies including Chengdu Better Pharmaceuticals, Qingdao Baiyang Pharmaceuticals, and Zhejiang Asia-Pacific Pharmaceuticals submitted listing applications and are under review and approval
.
Source: official website of the State Food and Drug Administration, Mi Nei.
com database
com database
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
The above sales are calculated based on the average retail price of the product at the terminal
.
A few days ago, the official website of the State Food and Drug Administration showed that the febuxostat tablets of Shandong Langnuo Pharmaceutical and the febuxostat tablets of Chongqing Shenghuaxi Pharmaceutical Co.
, Ltd.
were approved for production in four categories on the same day, and they were deemed to have been reviewed
.
According to data from Meinenet, febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in Chinese cities.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%
.
, Ltd.
were approved for production in four categories on the same day, and they were deemed to have been reviewed
.
According to data from Meinenet, febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in Chinese cities.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%
.
November 19, 2021, the release of the drug approval document pending information release
Febuxostat is a xanthine oxidase inhibitor that reduces serum uric acid concentration by inhibiting uric acid synthesis, and is suitable for long-term treatment of hyperuricemia in patients with gout
.
.
TOP5 terminal anti-gout products in physical pharmacies in Chinese cities
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
Febuxostat tablets were developed by Japan's Teijin Pharmaceuticals and were approved for listing in the United States in 2009, and are now on the market in many countries and regions including China
.
According to data from Minai.
com, Febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in cities in China
.
.
According to data from Minai.
com, Febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in cities in China
.
2021E China's urban physical pharmacy terminal febuxostat brand pattern
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In 2020, the sales of febuxostat tablets in physical pharmacies in Chinese cities exceeded the 500 million mark, and it is expected to decline in 2021
.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%; Jiangsu Hengrui Pharmaceutical and Hangzhou Zhuyangxin Pharmaceutical rank second and third
.
.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%; Jiangsu Hengrui Pharmaceutical and Hangzhou Zhuyangxin Pharmaceutical rank second and third
.
Up to now, there are 10 manufacturers of febuxostat tablets, of which 9 companies including Jiangsu Wanbang Biochemical and Pharmaceutical Group and Jiangsu Hengrui Medicine have been evaluated
.
In addition, nine companies including Chengdu Better Pharmaceuticals, Qingdao Baiyang Pharmaceuticals, and Zhejiang Asia-Pacific Pharmaceuticals submitted listing applications and are under review and approval
.
.
In addition, nine companies including Chengdu Better Pharmaceuticals, Qingdao Baiyang Pharmaceuticals, and Zhejiang Asia-Pacific Pharmaceuticals submitted listing applications and are under review and approval
.
Source: official website of the State Food and Drug Administration, Mi Nei.
com database
com database
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
The above sales are calculated based on the average retail price of the product at the terminal
.
A few days ago, the official website of the State Food and Drug Administration showed that the febuxostat tablets of Shandong Langnuo Pharmaceutical and the febuxostat tablets of Chongqing Shenghuaxi Pharmaceutical Co.
, Ltd.
were approved for production in four categories on the same day, and they were deemed to have been reviewed
.
According to data from Meinenet, febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in Chinese cities.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%
.
, Ltd.
were approved for production in four categories on the same day, and they were deemed to have been reviewed
.
According to data from Meinenet, febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in Chinese cities.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%
.
November 19, 2021, the release of the drug approval document pending information release
Febuxostat is a xanthine oxidase inhibitor that reduces serum uric acid concentration by inhibiting uric acid synthesis, and is suitable for long-term treatment of hyperuricemia in patients with gout
.
.
TOP5 terminal anti-gout products in physical pharmacies in Chinese cities
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
Febuxostat tablets were developed by Japan's Teijin Pharmaceuticals and were approved for listing in the United States in 2009, and are now on the market in many countries and regions including China
.
According to data from Minai.
com, Febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in cities in China
.
Medicine medicine medicine pharmacy pharmacy pharmacy.
According to data from Minai.
com, Febuxostat tablets are the TOP1 product of terminal anti-gout preparations in physical pharmacies in cities in China
.
2021E China's urban physical pharmacy terminal febuxostat brand pattern
Source: Mi Nei.
com, China's urban physical pharmacy terminal competition pattern
com, China's urban physical pharmacy terminal competition pattern
In 2020, the sales of febuxostat tablets in physical pharmacies in Chinese cities exceeded the 500 million mark, and it is expected to decline in 2021
.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%; Jiangsu Hengrui Pharmaceutical and Hangzhou Zhuyangxin Pharmaceutical rank second and third
.
.
Among them, Jiangsu Wanbang Biochemical Pharmaceutical Group has the largest market share, exceeding 50%; Jiangsu Hengrui Pharmaceutical and Hangzhou Zhuyangxin Pharmaceutical rank second and third
.
Up to now, there are 10 manufacturers of febuxostat tablets, of which 9 companies including Jiangsu Wanbang Biochemical and Pharmaceutical Group and Jiangsu Hengrui Medicine have been evaluated
.
In addition, nine companies including Chengdu Better Pharmaceuticals, Qingdao Baiyang Pharmaceuticals, and Zhejiang Asia-Pacific Pharmaceuticals submitted listing applications and are under review and approval
.
.
In addition, nine companies including Chengdu Better Pharmaceuticals, Qingdao Baiyang Pharmaceuticals, and Zhejiang Asia-Pacific Pharmaceuticals submitted listing applications and are under review and approval
.
Source: official website of the State Food and Drug Administration, Mi Nei.
com database
com database
Note: Meinenet China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 cities and above cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories
.
The above sales are calculated based on the average retail price of the product at the terminal
.
.
The above sales are calculated based on the average retail price of the product at the terminal
.
